First Citizens Bank & Trust Co. reduced its stake in shares of UnitedHealth Group Inc. (NYSE:UNH) by 19.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 90,164 shares of the healthcare conglomerate’s stock after selling 21,794 shares during the period. UnitedHealth Group comprises about 1.1% of First Citizens Bank & Trust Co.’s investment portfolio, making the stock its 14th largest position. First Citizens Bank & Trust Co.’s holdings in UnitedHealth Group were worth $12,731,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Kanaly Trust Co raised its stake in shares of UnitedHealth Group by 0.6% in the second quarter. Kanaly Trust Co now owns 1,772 shares of the healthcare conglomerate’s stock valued at $250,000 after buying an additional 11 shares during the last quarter. First Financial Bank N.A. Trust Division raised its position in UnitedHealth Group by 0.3% in the second quarter. First Financial Bank N.A. Trust Division now owns 7,847 shares of the healthcare conglomerate’s stock valued at $1,108,000 after buying an additional 21 shares in the last quarter. Capital One National Association raised its position in UnitedHealth Group by 0.3% in the second quarter. Capital One National Association now owns 8,250 shares of the healthcare conglomerate’s stock valued at $1,164,000 after buying an additional 25 shares in the last quarter. Osborn Rohs Williams & Donohoe Ltd raised its position in UnitedHealth Group by 0.4% in the second quarter. Osborn Rohs Williams & Donohoe Ltd now owns 8,984 shares of the healthcare conglomerate’s stock valued at $1,269,000 after buying an additional 33 shares in the last quarter. Finally, Capital Investment Advisors LLC raised its position in UnitedHealth Group by 0.6% in the second quarter. Capital Investment Advisors LLC now owns 6,667 shares of the healthcare conglomerate’s stock valued at $941,000 after buying an additional 38 shares in the last quarter. Hedge funds and other institutional investors own 85.78% of the company’s stock.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 2.25% during trading on Tuesday, reaching $134.98. 1,618,000 shares of the company’s stock traded hands. The company has a market cap of $128.55 billion, a price-to-earnings ratio of 21.12 and a beta of 0.57. The company’s 50-day moving average is $137.69 and its 200 day moving average is $136.52. UnitedHealth Group Inc. has a 52-week low of $107.51 and a 52-week high of $144.48.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The business earned $46.50 billion during the quarter, compared to analyst estimates of $45.05 billion. Equities analysts forecast that UnitedHealth Group Inc. will post $7.90 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were given a dividend of $0.625 per share. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a yield of 1.81%. UnitedHealth Group’s payout ratio is presently 39.12%.

UNH has been the topic of several recent analyst reports. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research note on Sunday, August 21st. Sanford C. Bernstein restated an “outperform” rating and set a $178.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, September 6th. Royal Bank Of Canada boosted their price objective on shares of UnitedHealth Group from $157.00 to $165.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 20th. Credit Suisse Group AG restated a “buy” rating and set a $148.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, June 29th. Finally, Zacks Investment Research lowered shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Monday, July 18th. One research analyst has rated the stock with a hold rating, twenty-five have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $155.35.

In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the sale, the director now directly owns 2,003,550 shares in the company, valued at $271,100,350.50. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.